199 related articles for article (PubMed ID: 35896822)
1. Predictors of clonal evolution and myeloid neoplasia following immunosuppressive therapy in severe aplastic anemia.
Groarke EM; Patel BA; Shalhoub R; Gutierrez-Rodrigues F; Desai P; Leuva H; Zaimoku Y; Paton C; Spitofsky N; Lotter J; Rios O; Childs RW; Young DJ; Dulau-Florea A; Dunbar CE; Calvo KR; Wu CO; Young NS
Leukemia; 2022 Sep; 36(9):2328-2337. PubMed ID: 35896822
[TBL] [Abstract][Full Text] [Related]
2. Relapse and transformation to myelodysplastic syndrome and acute myeloid leukemia following immunosuppressive therapy for aplastic anemia is more common as compared to allogeneic stem cell transplantation with a negative impact on survival.
Chattopadhyay S; Lionel S; Selvarajan S; Devasia AJ; Korula A; Kulkarni U; Aboobacker FN; Lakshmi KM; Srivastava A; Mathews V; Abraham A; George B
Ann Hematol; 2024 Mar; 103(3):749-758. PubMed ID: 38242970
[TBL] [Abstract][Full Text] [Related]
3. Frontline Therapy Options for Adults With Newly Diagnosed Severe Aplastic Anemia: Intensive immunosuppressive Therapy Plus Eltrombopag or Matched Sibling Donor Hematopoietic Stem Cell Transplantation?
Huang LF; Li L; Jia JS; Yang Y; Lin SY; Meng FK; Zhang DH; He GS
Transplant Cell Ther; 2022 Sep; 28(9):586.e1-586.e7. PubMed ID: 35609866
[TBL] [Abstract][Full Text] [Related]
4. Long-term outcomes in patients with severe aplastic anemia treated with immunosuppression and eltrombopag: a phase 2 study.
Patel BA; Groarke EM; Lotter J; Shalhoub R; Gutierrez-Rodrigues F; Rios O; Quinones Raffo D; Wu CO; Young NS
Blood; 2022 Jan; 139(1):34-43. PubMed ID: 34525188
[TBL] [Abstract][Full Text] [Related]
5. [Clinical analysis on malignant clonal hematopoiesis in severe aplastic anemia patients with immunosuppressive therapy].
Cui N; Fu R; Qu W; Ruan E; Wang X; Wang G; Wu Y; Liu H; Guan J; Song J; Xing L; Li L; Jiang H; Liu H; Wang Y; Liu C; Zhang W; Wang H; Shao Z
Zhonghua Yi Xue Za Zhi; 2015 Aug; 95(32):2620-2. PubMed ID: 26711612
[TBL] [Abstract][Full Text] [Related]
6. The Case for Upfront HLA-Matched Unrelated Donor Hematopoietic Stem Cell Transplantation as a Curative Option for Adult Acquired Severe Aplastic Anemia.
Marsh JCW; Risitano AM; Mufti GJ
Biol Blood Marrow Transplant; 2019 Sep; 25(9):e277-e284. PubMed ID: 31129354
[TBL] [Abstract][Full Text] [Related]
7. [Clinical characteristics of clonal evolution after immunosuppressive therapy in children with severe/very severe aplastic anemia].
Zhang JL; Liu TF; Chang LX; Chen X; Ren YY; Sun CC; Liu C; An WB; Wan Y; Chen XJ; Yang WY; Wang SC; Guo Y; Zou Y; Chen YM; Zhu XF
Zhongguo Dang Dai Er Ke Za Zhi; 2017 Jan; 19(1):27-33. PubMed ID: 28100318
[TBL] [Abstract][Full Text] [Related]
8. Clonal hematopoiesis in acquired aplastic anemia.
Ogawa S
Blood; 2016 Jul; 128(3):337-47. PubMed ID: 27121470
[TBL] [Abstract][Full Text] [Related]
9. Immunosuppressive therapy in severe aplastic anemia.
Patel BA; Townsley DM; Scheinberg P
Semin Hematol; 2022 Jan; 59(1):21-29. PubMed ID: 35491055
[TBL] [Abstract][Full Text] [Related]
10. Somatic Mutations and Clonal Hematopoiesis in Aplastic Anemia.
Yoshizato T; Dumitriu B; Hosokawa K; Makishima H; Yoshida K; Townsley D; Sato-Otsubo A; Sato Y; Liu D; Suzuki H; Wu CO; Shiraishi Y; Clemente MJ; Kataoka K; Shiozawa Y; Okuno Y; Chiba K; Tanaka H; Nagata Y; Katagiri T; Kon A; Sanada M; Scheinberg P; Miyano S; Maciejewski JP; Nakao S; Young NS; Ogawa S
N Engl J Med; 2015 Jul; 373(1):35-47. PubMed ID: 26132940
[TBL] [Abstract][Full Text] [Related]
11. Matched related transplantation versus immunosuppressive therapy plus eltrombopag for first-line treatment of severe aplastic anemia: a multicenter, prospective study.
Liu L; Lei M; Fu R; Han B; Zhao X; Liu R; Zhang Y; Jiao W; Miao M; Zhang F; Zhang L; Wu D
J Hematol Oncol; 2022 Aug; 15(1):105. PubMed ID: 35962406
[TBL] [Abstract][Full Text] [Related]
12. [Chronologic analysis of clonal evolution in acquired aplastic anemia and sMDS].
Yoshizato T
Rinsho Ketsueki; 2016 Apr; 57(4):430-9. PubMed ID: 27169446
[TBL] [Abstract][Full Text] [Related]
13. Relapse and clonal disease in children with aplastic anemia (AA) after immunosuppressive therapy (IST): the SAA 94 experience. German/Austrian Pediatric Aplastic Anemia Working Group.
Führer M; Burdach S; Ebell W; Gadner H; Haas R; Harbott J; Janka-Schaub G; Klingebiel T; Kremens B; Niemeyer C; Rampf U; Reiter A; Ritter J; Schulz A; Walther U; Zeidler C; Bender-Götze C
Klin Padiatr; 1998; 210(4):173-9. PubMed ID: 9743949
[TBL] [Abstract][Full Text] [Related]
14. Aplastic anemia: therapeutic updates in immunosuppression and transplantation.
Scheinberg P
Hematology Am Soc Hematol Educ Program; 2012; 2012():292-300. PubMed ID: 23233595
[TBL] [Abstract][Full Text] [Related]
15. [Allo-HSCT for acute myeloid leukemia with myelodysplastic-related changes: a clinical analysis].
Zhang HX; Pang AM; Chen X; Zhang RL; Zhai WH; Ma QL; Yang DL; Wei JL; He Y; Feng SZ; Han MZ; Jiang EL
Zhonghua Xue Ye Xue Za Zhi; 2021 Oct; 42(10):814-822. PubMed ID: 34788920
[No Abstract] [Full Text] [Related]
16. A real-word experience of eltrombopag plus rabbit antithymocyte immunoglobulin-based IST in Chinese patients with severe aplastic anemia.
Jin Y; Li R; Lin S; Jia J; Yang Y; Zhang D; He G; Li J
Ann Hematol; 2022 Nov; 101(11):2413-2419. PubMed ID: 36028583
[TBL] [Abstract][Full Text] [Related]
17. Long-term effects of hematopoietic growth factors in aplastic anemia patients treated with immunosuppression: Meta-analysis of randomized controlled trials.
Wang A; Su D; Luo J; Fu Y; Li Q; Chen S
Medicine (Baltimore); 2022 Oct; 101(42):e31103. PubMed ID: 36281138
[TBL] [Abstract][Full Text] [Related]
18. Very long-term follow-up of aplastic anemia treated with immunosuppressive therapy or allogeneic hematopoietic cell transplantation.
Drexler B; Zurbriggen F; Diesch T; Viollier R; Halter JP; Heim D; Holbro A; Infanti L; Buser A; Gerull S; Medinger M; Tichelli A; Passweg JR
Ann Hematol; 2020 Nov; 99(11):2529-2538. PubMed ID: 32948913
[TBL] [Abstract][Full Text] [Related]
19. Comparison of Outcomes of Frontline Immunosuppressive Therapy and Frontline Haploidentical Hematopoietic Stem Cell Transplantation for Children with Severe Aplastic Anemia Who Lack an HLA-Matched Sibling Donor.
Yang S; Yuan X; Ma R; Jiang L; Guo J; Zang Y; Shi J; Yang J; Lei P; Liu Z; Zhang Y; Zhu Z
Biol Blood Marrow Transplant; 2019 May; 25(5):975-980. PubMed ID: 30658223
[TBL] [Abstract][Full Text] [Related]
20. First-line immunosuppressive therapy with rATG and CsA for severe aplastic anemia: 15 years' experience.
Hu J; Zhang L; Zhao X; Liu X; Jing L; Zhou K; Li Y; Li Y; Li J; Ye L; Peng G; Fan H; Yang W; Yang Y; Xiong Y; Song L; Zhang F
Ann Hematol; 2022 Nov; 101(11):2405-2412. PubMed ID: 36151352
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
